Persistently positive gliadin antibodies without transglutaminase antibodies in the elderly: Gluten intolerance beyond coeliac disease

Digestive and Liver Disease

Volumn 43, Issue 10, 2011, Pages 772-778

  Ruuskanen, Anitta ^a   Luostarinen, Liisa ^a   Collin, Pekka ^b   Krekelä, Ilkka ^a   Patrikainen, Heikki ^a   Tillonen, Jyrki ^a   Laurila, Kaija ^c   Haimila, Katri ^d   Partanen, Jukka ^d   Mäki, Markku ^c   Valve, Raisa ^e   Kaukinen, Katri ^b  

^a PÄIJÄT HÄME CENTRAL HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c TAMPERE UNIVERSITY OF TECHNOLOGY   (Finland)

^d FINNISH RED CROSS BLOOD SERVICE   (Finland)

^e UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Coeliac disease; Gliadin antibodies; Gluten; Transglutaminase antibodies

Indexed keywords

CD3 ANTIGEN; GLIADIN ANTIBODY; GLUTEN; HLA DQA1 ANTIGEN; HLA DQB1 ANTIGEN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE ANTIBODY;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CELIAC DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DUODENOSCOPY; FOLLOW UP; GAMMA DELTA T LYMPHOCYTE; GASTROINTESTINAL SYMPTOM; HUMAN; HUMAN TISSUE; IMMUNOGLOBULIN BLOOD LEVEL; INTESTINE BIOPSY; PRIORITY JOURNAL; STOMACH BIOPSY;

AGED; AGED, 80 AND OVER; ANTIBODIES; ANTIGENS, CD3; BIOPSY; CELIAC DISEASE; DUODENUM; ENDOSCOPY, DIGESTIVE SYSTEM; FEMALE; GLIADIN; HLA-DQ ANTIGENS; HUMANS; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INTESTINAL MUCOSA; LYMPHOCYTES; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRANSGLUTAMINASES;

EID: 80052515121     PISSN: 15908658     EISSN: 18783562     Source Type: Journal    
DOI: 10.1016/j.dld.2011.04.025     Document Type: Article

References (42)

1. Rostom A., Dube C., Cranney A., et al. The diagnostic accuracy of serologic tests for celiac disease: a systematic review. Gastroenterology 2005, 128:S38-S46.
2. Marsh M.N. Gluten, major histocompatibility complex, and the small intestine. A molecular and immunobiologic approach to the spectrum of gluten sensitivity ('celiac sprue'). Gastroenterology 1992, 102:330-354.
3. Paparo F., Petrone E., Tosco A., et al. Clinical, HLA, and small bowel immunohistochemical features of children with positive serum antiendomysium antibodies and architecturally normal small intestinal mucosa. Am J Gastroenterol 2005, 100:2294-2298.
4. Salmi T.T., Collin P., Jarvinen O., et al. Immunoglobulin A autoantibodies against transglutaminase 2 in the small intestinal mucosa predict forthcoming coeliac disease. Aliment Pharmacol Ther 2006, 24:541-552.
5. Kurppa K., Collin P., Viljamaa M., et al. Diagnosing mild enteropathy celiac disease: a randomized, controlled clinical study. Gastroenterology 2009, 136:816-823.
6. Collin P., Helin H., Maki M., et al. Follow-up of patients positive in reticulin and gliadin antibody tests with normal small-bowel biopsy findings. Scand J Gastroenterol 1993, 28:595-598.
7. Kaukinen K., Collin P., Holm K., et al. Small-bowel mucosal inflammation in reticulin or gliadin antibody-positive patients without villous atrophy. Scand J Gastroenterol 1998, 33:944-949.
8. Corazza G., Valentini R.A., Frisoni M., et al. Gliadin immune reactivity is associated with overt and latent enteropathy in relatives of celiac patients. Gastroenterology 1992, 103:1517-1522.
9. Vazquez H., Cabanne A., Sugai E., et al. Serological markers identify histologically latent coeliac disease among first-degree relatives. Eur J Gastroenterol Hepatol 1996, 8:15-21.
10. Bonamico M., Ballati G., Mariani P., et al. Screening for coeliac disease: the meaning of low titers of anti-gliadin antibodies (AGA) in non-coeliac children. Eur J Epidemiol 1997, 13:55-59.
11. Johnston S.D., Watson R.G., McMillan S.A., et al. Serological markers for coeliac disease: changes with time and relationship to enteropathy. Eur J Gastroenterol Hepatol 1998, 10:259-264.
12. Laass M.W., Koch T., Losel A., et al. Longitudinal follow-up examination of antigliadin antibody positive children and adults. Eur J Gastroenterol Hepatol 2006, 18:503-506.
13. Ruuskanen A., Kaukinen K., Collin P., et al. Positive serum antigliadin antibodies without celiac disease in the elderly population: does it matter?. Scand J Gastroenterol 2010, 45:1197-1202.
14. Kaukinen K., Collin P., Laurila K., et al. Resurrection of gliadin antibodies in coeliac disease. Deamidated gliadin peptide antibody test provides additional diagnostic benefit. Scand J Gastroenterol 2007, 42:1428-1433.
15. Volta U., Granito A., Fiorini E., et al. Usefulness of antibodies to deamidated gliadin peptides in celiac disease diagnosis and follow-up. Dig Dis Sci 2008, 53:1582-1588.
16. GOAL. Good aging in the Lahti region=GOAL. http://www.palmenia.helsinki.fi/ikihyva/inenglish.html.
17. Karell K., Louka A.S., Moodie S.J., et al. HLA types in celiac disease patients not carrying the DQA1*05-DQB1*02 (DQ2) heterodimer: results from the European genetics cluster on celiac disease. Hum Immunol 2003, 64:469-477.
18. Vainio E., Kalimo K., Reunala T., et al. Circulating IgA- and IgG-class antigliadin antibodies in dermatitis herpetiformis detected by enzyme-linked immunosorbent assay. Arch Dermatol Res 1983, 275:15-18.
19. Svedlund J., Sjodin I., Dotevall G. GSRS-a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci 1988, 33:129-134.
20. Dimenas E., Carlsson G., Glise H., et al. Relevance of norm values as part of the documentation of quality of life instruments for use in upper gastrointestinal disease. Scand J Gastroenterol Suppl 1996, 221:8-13.
21. Midhagen G., Hallert C. High rate of gastrointestinal symptoms in celiac patients living on a gluten-free diet: controlled study. Am J Gastroenterol 2003, 98:2023-2026.
22. Salmi T.T., Collin P., Korponay-Szabo I.R., et al. Endomysial antibody-negative coeliac disease: clinical characteristics and intestinal autoantibody deposits. Gut 2006, 55:1746-1753.
23. Jarvinen T.T., Kaukinen K., Laurila K., et al. Intraepithelial lymphocytes in celiac disease. Am J Gastroenterol 2003, 98:1332-1337.
24. Korponay-Szabo I.R., Halttunen T., Szalai Z., et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004, 53:641-648.
25. Simell S., Hoppu S., Hekkala A., et al. Fate of five celiac disease-associated antibodies during normal diet in genetically at-risk children observed from birth in a natural history study. Am J Gastroenterol 2007, 102:2026-2035.
26. Vilppula A., Kaukinen K., Luostarinen L., et al. Increasing prevalence and high incidence of celiac disease in elderly people: a population-based study. BMC Gastroenterol 2009, 9:49.
27. Vande Voort J.L., Murray J.A., Lahr B.D., et al. Lymphocytic duodenosis and the spectrum of celiac disease. Am J Gastroenterol 2009, 104:142-148.
28. Aziz I., Evans K.E., Hopper A.D., et al. A prospective study into the aetiology of lymphocytic duodenosis. Aliment Pharmacol Ther 2010, 32.
29. Walker M.M., Murray J.A., Ronkainen J., et al. Detection of celiac disease and lymphocytic enteropathy by parallel serology and histopathology in a population-based study. Gastroenterology 2010, 139:112-119.
30. Gonzalez S., Gupta A., Cheng J., et al. Prospective study of the role of duodenal bulb biopsies in the diagnosis of celiac disease. Gastrointest Endosc 2010, 72:758-765.
31. McMillan S.A., Watson R.P., McCrum E.E., Evans A.E. Factors associated with serum antibodies to reticulin, ednoysium, and gliadin in an adult population. Gut 1996, 39:43-47.
32. Salomaa-Rasanen A., Kosunen T.U., Aromaa A.R., et al. A "screen-and-treat" approach for Helicobacter pylori infection: a population-based study in Vammala, Finland. Helicobacter 2010, 15:28-37.
33. Kaukinen K., Turjanmaa K., Maki M., et al. Intolerance to cereals is not specific for coeliac disease. Scand J Gastroenterol 2000, 35:942-946.
34. Wahnschaffe U., Ullrich R., Riecken E.O., Schulzke J.D. Celiac disease-like abnormalities in a subgroup of patients with irritable bowel syndrome. Gastroenterology 2001, 121:1329-1338.
35. Verdu E.F., Armstrong D., Murray J.A. Between celiac disease and irritable bowel syndrome: the "no man's land" of gluten sensitivity. Am J Gastroenterol 2009, 104:1587-1594.
36. Biesiekierski J.R., Newnham E.D., Irving P.M., et al. Gluten causes gastrointestinal symptoms in subjects without celiac disease: a double-blind randomized placebo-controlled trial. Am J Gastroenterol 2011, 106:508-514.
37. Wahnschaffe U., Schulzke J.D., Zeitz M., Ullrich R. Predictors of clinical response to gluten-free diet in patients diagnosed with diarrhea-predominant irritable bowel syndrome. Clin Gastroenterol Hepatol 2007, 5:50.
38. Cinova J., Palova-Jelinkova L., Smythies L.E., et al. Gliadin peptides activate blood monocytes from patients with celiac disease. J Clin Immunol 2007, 27:201-209.
39. Zhou Q., Souba W.W., Croce C.M., Verne G.N. MicroRNA-29a regulates intestinal membrane permeability in patients with irritable bowel syndrome. Gut 2010, 59:775-784.
40. Wolters V.M., Alizadeh B.Z., Weijerman M.E., et al. Intestinal barrier gene variants may not explain the increased levels of antigliadin antibodies, suggesting other mechanisms than altered permeability. Hum Immunol 2010, 71:392-396.
41. Verdu E.F., Huang X., Natividad J., et al. Gliadin-dependent neuromuscular and epithelial secretory responses in gluten-sensitive HLA-DQ8 transgenic mice. Am J Physiol Gastrointest Liver Physiol 2008, 294:G217-G225.
42. Sapone A., Lammers K.M., Casolaro V., et al. Divergence of gut permeability and mucosal immune expression in two gluten-associated conditions: celiac disease and gluten sensitivity. BMC Med 2011, 9:23.